Regeneron Pharmaceuticals (NQ: REGN )
1,178.74
+3.41
(+0.29%)
Streaming Delayed Price
Updated: 3:55 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Regeneron Pharmaceuticals![]() Via Benzinga
![]()
Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug
April 11, 2024
Via Benzinga
Topics
Fraud
Exposures
Legal
![]() ![]() ![]() ![]() Via Benzinga
![]() Via Benzinga
![]() Via GlobeNewswire
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
FDA Delays Decision For Regeneron's Inaugural Blood Cancer Therapy, Highlights Trial Concerns
March 25, 2024
Via Benzinga
Exposures
Product Safety
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via GlobeNewswire
![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|